ATE428779T1 - Verfahren zur ortspezifischen massenmutagenese - Google Patents
Verfahren zur ortspezifischen massenmutageneseInfo
- Publication number
- ATE428779T1 ATE428779T1 AT04292987T AT04292987T ATE428779T1 AT E428779 T1 ATE428779 T1 AT E428779T1 AT 04292987 T AT04292987 T AT 04292987T AT 04292987 T AT04292987 T AT 04292987T AT E428779 T1 ATE428779 T1 AT E428779T1
- Authority
- AT
- Austria
- Prior art keywords
- library
- mutagenesis
- generating
- site
- specific mass
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000002703 mutagenesis Methods 0.000 title abstract 2
- 231100000350 mutagenesis Toxicity 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 108091034117 Oligonucleotide Proteins 0.000 abstract 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 4
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 230000002194 synthesizing effect Effects 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0314892 | 2003-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE428779T1 true ATE428779T1 (de) | 2009-05-15 |
Family
ID=34508693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04292987T ATE428779T1 (de) | 2003-12-18 | 2004-12-14 | Verfahren zur ortspezifischen massenmutagenese |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20050153343A1 (de) |
| EP (1) | EP1544296B8 (de) |
| AT (1) | ATE428779T1 (de) |
| DE (1) | DE602004020570D1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060199250A1 (en) * | 2005-03-04 | 2006-09-07 | Huimin Zhao | Method for generating a mutant protein which efficiently binds a target molecule |
| DK2339014T3 (en) * | 2005-11-16 | 2015-07-20 | Ambrx Inc | Methods and compositions comprising non-natural amino acids |
| KR100784478B1 (ko) * | 2005-12-05 | 2007-12-11 | 한국과학기술원 | 기능요소의 동시 삽입에 의한 신기능을 갖는 단백질을제조하는 방법 |
| EP2078077A2 (de) * | 2006-10-04 | 2009-07-15 | Codon Devices, Inc | Nukleinsäurebibliotheken und ihr entwurf und herstellung |
| CA2913029A1 (en) * | 2012-12-10 | 2014-06-19 | Fred Hutchinson Cancer Research Center | Lipocalin fusion partners |
| WO2021136194A1 (zh) * | 2019-12-30 | 2021-07-08 | 南京金斯瑞生物科技有限公司 | 构建基因突变文库的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6479258B1 (en) * | 1995-12-07 | 2002-11-12 | Diversa Corporation | Non-stochastic generation of genetic vaccines |
| ATE296310T1 (de) * | 1999-03-08 | 2005-06-15 | Metrigen Inc | Syntheseverfahren zum ökonomischen aufbau langer dna-sequenzen und zusammensetzungen hierfür |
| FR2813314B1 (fr) * | 2000-08-25 | 2004-05-07 | Biomethodes | Procede de mutagenese dirigee massive |
| FR2826957B1 (fr) * | 2001-07-09 | 2005-09-30 | Centre Nat Rech Scient | Procede de fonctionnalisation de supports solides, supports solides fonctionnalises et leurs utilisations |
| US20030219781A1 (en) * | 2002-01-14 | 2003-11-27 | Diversa Corporation | Compositions and methods for making polynucleotides by iterative assembly of codon building blocks |
-
2004
- 2004-12-14 DE DE602004020570T patent/DE602004020570D1/de not_active Expired - Lifetime
- 2004-12-14 AT AT04292987T patent/ATE428779T1/de not_active IP Right Cessation
- 2004-12-14 EP EP04292987A patent/EP1544296B8/de not_active Expired - Lifetime
- 2004-12-15 US US11/012,068 patent/US20050153343A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1544296B8 (de) | 2009-08-05 |
| EP1544296B1 (de) | 2009-04-15 |
| US20050153343A1 (en) | 2005-07-14 |
| EP1544296A1 (de) | 2005-06-22 |
| DE602004020570D1 (de) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6206943B2 (ja) | ペプチドライブラリーの製造方法、ペプチドライブラリー、及びスクリーニング方法 | |
| DE69942701D1 (de) | Kontinuierliche in vitro-evolution. | |
| ATE388228T1 (de) | Verfahren zur verknüpfung interessierender sequenzen | |
| DE602004025805D1 (de) | Verfahren zur herstellung von antikörpern | |
| HUP0300369A2 (hu) | Többértékű antitestek és alkalmazásuk | |
| JP2010535150A5 (de) | ||
| WO2003075129A3 (en) | Methods, systems, and software for identifying functional bio-molecules | |
| DK0988378T4 (da) | En fremgangsmåde til in vitro molekylær udvikling af proteinfunktion | |
| EP4253549A3 (de) | Verbessertes kombinatorisches genetisches modifikationssystem mit hohem durchsatz und optimierte cas9-enzymvarianten | |
| ATE428779T1 (de) | Verfahren zur ortspezifischen massenmutagenese | |
| AU2003270022A1 (en) | Method and apparatus for the manufacture of high temperature materials by combustion synthesis and semi-solid forming | |
| EP1606300A4 (de) | Für predeterminierte proteinfamilien optimierte sirna-bibliotheken | |
| WO2005040073A3 (en) | Solid phase synthesis of 3-aryl-2- indolylcarboxylic acids | |
| DE602005022443D1 (de) | Schnelle synthese von oligonukleotiden | |
| WO2001075091A3 (en) | A method for in vitro molecular evolution of antibody function | |
| WO2004046340A3 (en) | Intron fusion construct and method of using for selecting high-expressing production cell lines | |
| WO2003091416A3 (en) | Constant length signatures for parallel sequencing of polynucleotides | |
| ATE278702T1 (de) | Verfahren zur synthese von phosphorothioat- oligonukelotiden | |
| FI3692140T3 (fi) | Menetelmiä solujen laajentamiseksi selektiivisesti ekspressoiden TCR:ää vakiolla muriinialueella | |
| DK1948794T3 (da) | Fremgangsmåde til molekylær evolution in vitro af proteinfunktion | |
| BR0311578A (pt) | seqüências de receptores cdr3 de células t e métodos para detecção | |
| JP2016098198A (ja) | Ｄｎａライブラリの製造方法、ｄｎａライブラリ、スクリーニング方法及びスクリーニングキット | |
| WO2005040344A3 (en) | Generation of stabilized proteins by combinatorial consensus mutagenesis | |
| NO20063125L (no) | Fremgangsmate og anordning for kontinuerlig fremstilling av en pyroteknisk gjenstand | |
| Ueno et al. | Peptide ligase–mediated display: A cell-free platform for tunable selection of affinity peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |